サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1291619

自己幹細胞および非幹細胞療法市場：タイプ、用途、エンドユーザー、地域別、2023-2028年

Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Type, Application, End User, and Region 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 144 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
自己幹細胞および非幹細胞療法市場：タイプ、用途、エンドユーザー、地域別、2023-2028年
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要：

自己幹細胞および非幹細胞療法の世界市場規模は、2022年に67億3,000万米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に13.60%の成長率（CAGR）を示し、2028年までに153億9,000万米ドルに達すると予測しています。生命を脅かす疾患の増加、高齢者人口の増加、幹細胞技術の継続的な進歩が、市場を牽引する主要な要因の一つです。

自己幹細胞療法は、患者の幹細胞を用いて損傷した組織や臓器を修復したり、様々な病気を治療する医療処置です。この治療法では、患者の体内から幹細胞を採取し、通常は骨髄や脂肪組織から採取し、加工して体内に戻します。一方、非幹細胞療法は、幹細胞ではない細胞、例えば免疫細胞、線維芽細胞、筋肉細胞などを用いて、損傷した組織や臓器を修復・再生させるものです。自己幹細胞療法は、心血管疾患、神経変性疾患、自己免疫疾患の治療に用いられ、非幹細胞療法は、慢性創傷、心臓病、パーキンソン病の治療に採用されています。

自己幹細胞および非幹細胞療法の市場動向：

自己幹細胞および非幹細胞療法の世界市場の成長は、主に消費者の喫煙、食生活の乱れ、座りがちなライフスタイルによる、がん、糖尿病、心血管障害、神経変性疾患の有病率の増加によって牽引されています。このほか、高齢者人口の増加や、自己幹細胞および非幹細胞療法の治療に対する需要の高まりが、市場に明るい展望をもたらしています。さらに、再生医療のための革新的な自己幹細胞療法の開発が進み、個別化治療への需要が広がっていることが、市場に有益な成長機会をもたらしています。さらに、低侵襲治療の人気の高まり、幹細胞治療の受け入れ拡大、幹細胞研究に対する財政的・規制的支援など、政府の有利な取り組みの実施も、市場拡大の一助となっています。さらに、幹細胞技術の継続的な進歩により、研究開発者は幹細胞の分化をより適切に制御し、改善された効果的な治療法を開発できるようになり、これが重要な成長促進要因として作用しているのです。このほか、ヘルスケア分野の成長促進、広範な研究開発活動、消費者の健康意識の高まり、有利な償還政策などが、市場の成長に寄与しています。

本レポートで扱う主な質問

  • 自己幹細胞および非幹細胞療法の世界市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • 世界の自己幹細胞および非幹細胞療法の治療薬市場における市場促進要因、抑制要因、および機会は何か？
  • 各駆動要因、抑制要因、機会が世界の自己幹細胞および非幹細胞療法市場に与える影響とは？
  • 主要な地域市場とは？
  • 最も魅力的な自己幹細胞および非幹細胞療法市場を代表する国はどこか？
  • 市場内訳のタイプ別内訳は？
  • 自己幹細胞および非幹細胞療法の治療市場において、最も魅力的なタイプは何か？
  • 用途に基づく市場の内訳は？
  • 自己幹細胞および非幹細胞療法市場で最も魅力的な用途はどれか？
  • エンドユーザーに基づく市場の内訳は？
  • 自己幹細胞・非幹細胞治療薬市場において最も魅力的なエンドユーザーはどこか？
  • 世界の自己幹細胞および非幹細胞療法の治療薬市場の競争構造は？
  • 世界の自己幹細胞および非幹細胞療法の治療薬市場における主要プレイヤー/企業はどこか？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な業界動向

第5章 自己幹細胞および非幹細胞療法の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 タイプ別市場内訳

  • 自己幹細胞
    • 市場動向
    • 市場予測
  • 自己非幹細胞
    • 市場動向
    • 市場予測

第7章 用途別市場内訳

  • がん
    • 市場動向
    • 市場予測
  • 神経変性疾患
    • 市場動向
    • 市場予測
  • 循環器疾患
    • 市場動向
    • 市場予測
  • 整形外科疾患
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 エンドユーザー別市場内訳

  • 病院
    • 市場動向
    • 市場予測
  • 外来手術センター
    • 市場動向
    • 市場予測
  • 調査研究施設
    • 市場動向
    • 市場予測

第9章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場予測

第10章 促進要因・抑制要因・機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第11章 バリューチェーン分析

第12章 バリューチェーン分析ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • BrainStorm Cell Limited
    • Cytori Therapeutics Inc.
    • Holostem Terapie Avanzate S.r.l.
    • Lisata Therapeutics
    • U.S. Stem Cell Inc.

本レポートに掲載されている企業名は一部であり、全企業名は本レポートに掲載されています。

図表

List of Figures

  • Figure 1: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Major Drivers and Challenges
  • Figure 2: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Autologous Stem Cells) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Autologous Stem Cells) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Autologous Non-Stem Cells) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Autologous Non-Stem Cells) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Neurodegenerative Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Neurodegenerative Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Cardiovascular Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Cardiovascular Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Orthopedic Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Orthopedic Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Research Facilities) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies (Research Facilities) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia-Pacific: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia-Pacific: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Breakup by Country (in %), 2022
  • Figure 76: Middle East and Africa: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Industry: Drivers, Restraints, and Opportunities
  • Figure 78: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Industry: Value Chain Analysis
  • Figure 79: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Competitive Structure
  • Table 7: Global: Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Key Players
目次
Product Code: SR112023A7527

Market Overview:

The global autologous stem cell and non-stem cell based therapies market size reached US$ 6.73 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 15.39 Billion by 2028, exhibiting a growth rate (CAGR) of 13.60% during 2023-2028. The increasing prevalence of life-threatening diseases, the expanding geriatric population, and ongoing advancements in stem cell technologies represent some of the key factors driving the market.

Autologous stem cell therapy is a medical procedure in which a patient's stem cells are used to repair damaged tissues and organs or treat various diseases. The procedure involves harvesting stem cells from a patient's body, usually from bone marrow or adipose tissue, and then processing and injecting them back into the body. Non-stem cell-based therapies, on the other hand, involve using cells that are not stem cells, such as immune cells, fibroblasts, and muscle cells, to repair or regenerate damaged tissues or organs. Autologous stem cell therapy is used to treat cardiovascular diseases, neurodegenerative diseases, and autoimmune disorders, while non-stem cell-based therapies are employed in treating chronic wounds, heart disease, and Parkinson's disease.

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Trends:

The growth of the global autologous stem cell and non-stem cell based therapies market is primarily driven by the increasing prevalence of cancer, diabetes, cardiovascular disorders, and neurodegenerative diseases due to smoking, poor diet, and sedentary lifestyles of consumers. Besides this, the rising geriatric population and the growing demand for autologous stem and non-stem cell based therapies are creating a positive outlook for the market. Moreover, the ongoing development of innovative autologous stem cell therapies for regenerative medicine and the widespread demand for personalized therapies are presenting remunerative growth opportunities for the market. In addition to this, the surging popularity of minimally invasive treatments, the expanding acceptance of stem cell therapies, and the implementation of favorable government initiatives, such as financial and regulatory support for stem cell research, are aiding in market expansion. Furthermore, continuous advancements in stem cell technologies have enabled researchers to better control the differentiation of stem cells and develop improved and effective treatments, which, in turn, is acting as a significant growth-inducing factor. Besides this, the bolstering growth of the healthcare sector, extensive research and development (R&D) activities, the escalating health consciousness among consumers, and favorable reimbursement policies are contributing to the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global autologous stem cell and non-stem cell based therapies market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on type, application, and end user.

Type Insights:

  • Autologous Stem Cells
  • Autologous Non-Stem Cells

The report has provided a detailed breakup and analysis of the autologous stem cell and non-stem cell based therapies market based on the type. This includes autologous stem cells and autologous non-stem cells. According to the report, autologous stem cells represented the largest segment.

Application Insights:

  • Cancer
  • Neurodegenerative Disorders
  • Cardiovascular Disease
  • Orthopedic Diseases
  • Others

A detailed breakup and analysis of the autologous stem cell and non-stem cell based therapies market based on the application has also been provided in the report. This includes cancer, neurodegenerative disorders, cardiovascular disease, orthopedic diseases, and others. According to the report, cancer accounted for the largest market share.

End User Insights:

  • Hospitals
  • Ambulatory Surgical Centers
  • Research Facilities

The report has provided a detailed breakup and analysis of the autologous stem cell and non-stem cell based therapies market based on the end user. This includes hospitals, ambulatory surgical centers, and research facilities. According to the report, hospitals represented the largest segment.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for autologous stem cell and non-stem cell based therapies. Some of the factors driving the North America autologous stem cell and non-stem cell based therapies market included the expanding prevalence of chronic diseases, the rising demand for personalized medicines, and continuous advancements in stem cell technologies.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global autologous stem cell and non-stem cell based therapies market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include BrainStorm Cell Limited, Cytori Therapeutics Inc., Holostem Terapie Avanzate S.r.l., Lisata Therapeutics, U.S. Stem Cell Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global autologous stem cell and non-stem cell based therapies market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global autologous stem cell and non-stem cell based therapies market?
  • What is the impact of each driver, restraint, and opportunity on the global autologous stem cell and non-stem cell based therapies market?
  • What are the key regional markets?
  • Which countries represent the most attractive autologous stem cell and non-stem cell based therapies market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the autologous stem cell and non-stem cell based therapies market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the autologous stem cell and non-stem cell based therapies market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the autologous stem cell and non-stem cell based therapies market?
  • What is the competitive structure of the global autologous stem cell and non-stem cell based therapies market?
  • Who are the key players/companies in the global autologous stem cell and non-stem cell based therapies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Autologous Stem Cells
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Autologous Non-Stem Cells
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Neurodegenerative Disorders
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cardiovascular Disease
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Orthopedic Diseases
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Research Facilities
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 BrainStorm Cell Limited
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Cytori Therapeutics Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Holostem Terapie Avanzate S.r.l.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Lisata Therapeutics
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 U.S. Stem Cell Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.